Apolipoprotein E promoter and regulatory DNA (APOE promoter)

The Apolipoprotein E (APOE) promoter and regulatory DNA are critical genomic regions that control the transcription of the APOE gene, which encodes a major cholesterol carrier essential for lipid homeostasis in the brain and peripheral tissues (Maloney et al., 2007). This regulatory apparatus includes the proximal promoter and distal enhancers, such as the multi-enhancer elements ME1 and ME2, which integrate signals from nuclear receptors like Liver X Receptors (LXR) and Retinoid X Receptors (RXR) (Riddell et al., 2007). In Alzheimer's disease, the APOE ε4 allele is the most significant genetic risk factor, and its expression levels are closely linked to amyloid-beta accumulation and neuroinflammation (Corder et al., 1993). Therapeutic targeting of these regulatory sequences aims to modulate APOE expression to enhance amyloid clearance or reduce the toxic effects associated with specific isoforms. Emerging strategies include the use of CRISPR-based epigenome editors to silence the ε4 allele or small molecule agonists that promote APOE expression through its regulatory elements (Park et al., 2020). Because APOE is also vital for systemic lipid transport, targeting its regulatory DNA requires careful consideration of potential side effects like hypertriglyceridemia.

Other names

APOE promoter regionAPOE regulatory elementsAPOE proximal promoterAPOE distal enhancersAPOE multi-enhancer elementsAPOE ME1APOE ME2

Transcriptional modulation via the activation or repression of regulatory elements to control Apolipoprotein E protein levels.